Diagnostic efficacy of activated partial thromboplastin time waveform and procalcitonin analysis in pediatric meningococcal sepsis

被引:4
作者
Paize, Fauzia [1 ,2 ]
Carrol, Enitan [1 ,2 ]
Downey, Colin [5 ]
Parry, Christopher M. [2 ]
Green, Gerwyn [6 ]
Diggle, Peter [6 ]
Newland, Paul [4 ]
Riordan, F. A. I. [3 ]
Thomson, Alistair [1 ]
Hart, C. A. [2 ]
Toh, Cheng-Hock [2 ,5 ,7 ]
机构
[1] Univ Liverpool, Inst Child Hlth, Alder Hey Childrens Natl Hlth Serv NHS Fdn Trust, Liverpool L69 3BX, Merseyside, England
[2] Univ Liverpool, Dept Clin Infect Microbiol & Immunol, Liverpool L69 3BX, Merseyside, England
[3] Alder Hey Childrens NHS Fdn Trust, Dept Infect Dis, Liverpool, Merseyside, England
[4] Alder Hey Childrens NHS Fdn Trust, Dept Clin Biochem, Liverpool, Merseyside, England
[5] Royal Liverpool & Broadgreen Univ Hosp NHS Trust, Dept Haematol, Liverpool, Merseyside, England
[6] Univ Lancaster, Sch Hlth & Med, Lancaster, England
[7] Royal Liverpool & Broadgreen Univ Hosp NHS Trust, NIHR Biomed Res Ctr, Liverpool, Merseyside, England
关键词
aPTT waveform; children; coagulation; meningococcal disease; sepsis; C-REACTIVE PROTEIN; CRITICALLY-ILL PATIENTS; LOW-DENSITY LIPOPROTEIN; EARLY IDENTIFICATION; PROGNOSTIC IMPLICATIONS; MARKER; MORTALITY; CHILDREN; DISEASE; COAGULATION;
D O I
10.1097/PCC.0b013e3182231034
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: A biphasic activated partial thromboplastin time waveform predicts sepsis and disseminated intravascular coagulation in adults. This has not been previously investigated in children. Our aim is to ascertain whether there are changes in the activated partial thromboplastin time waveform in children with meningococcal disease and to compare its diagnostic use with procalcitonin. Setting: Alder Hey Children's National Health Service Foundation Trust, Liverpool, UK. Patients: Thirty-six children admitted to the hospital for the treatment of suspected meningococcal disease had activated partial thromboplastin time waveform and procalcitonin analysis performed at admission. The light transmittance level at 18 secs was used to quantitate the waveform. Severity of disease was assessed using the Glasgow Meningococcal Septicaemia Prognostic Score, Pediatric Risk of Mortality III score, and the Pediatric Logistic Organ Dysfunction score. Measurements and Main Results: Twenty-four children had proven meningococcal disease, 12 had a presumed viral illness, and 20 control subjects were recruited. Transmittance level at 18 secs was lower in children with meningococcal disease and those with a viral illness (p < .0001) and control subjects (p < .0005). Sensitivity and specificity was 0.91 and 0.96 for transmittance level at 18 secs and 0.92 and 1 for procalcitonin in identifying meningococcal disease. There was a significant difference in procalcitonin between children with meningococcal disease and those with a viral illness and control subjects (p < .0005). A negative correlation was found between transmittance level at 18 secs and length of hospital stay (p < .0001), C-reactive protein (p < .0001), procalcitonin (p < .0001), Glasgow Meningococcal Septicaemia Prognostic Score (p < .01), Pediatric Risk of Mortality III score (p < .0001), and Pediatric Logistic Organ Dysfunction score score (p < .0001). Conclusion: The activated partial thromboplastin time waveform is abnormal in children with meningococcal disease and may be a useful adjunct in the diagnosis and management of sepsis in children. (Pediatr Crit Care Med 2011; 12:e322-e329)
引用
收藏
页码:E322 / E329
页数:8
相关论文
共 50 条
  • [31] Isolated Prolongation of Activated Partial Thromboplastin Time: Not Just Bleeding Risk!
    Santoro, Rita Carlotta
    Molinari, Angelo Claudio
    Leotta, Marzia
    Martini, Tiziano
    MEDICINA-LITHUANIA, 2023, 59 (06):
  • [32] BEDSIDE MONITORING OF HEPARIN-THERAPY - COMPARISON OF ACTIVATED CLOTTING TIME TO ACTIVATED PARTIAL THROMBOPLASTIN TIME
    REINER, JS
    COYNE, KS
    LUNDERGAN, CF
    ROSS, AM
    CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS, 1994, 32 (01): : 49 - 52
  • [33] Prolonged activated partial thromboplastin time with no clear explanation
    Nakav, Sigal
    Blickstein, Dorit
    Raanani, Pia
    Rabizadeh, Esther
    Spectre, Galia
    BLOOD COAGULATION & FIBRINOLYSIS, 2020, 31 (03) : 225 - 228
  • [34] A laboratory evaluation into the short activated partial thromboplastin time
    Mina, Ashraf
    Favaloro, Emmanuel J.
    Mohammed, Soma
    Koutts, Jerry
    BLOOD COAGULATION & FIBRINOLYSIS, 2010, 21 (02) : 152 - 157
  • [35] The missing slope: paradoxical shortening of activated partial thromboplastin time in a patient on unfractionated heparin therapy
    Lapic, Ivana
    Vrancic, Ana Loncar
    Herak, Desiree Coen
    Rogic, Dunja
    BIOCHEMIA MEDICA, 2021, 31 (02) : 021003
  • [36] Effect of Pre-analytical Conditions on Prothrombin Time and Partial Activated Thromboplastin Time
    Beatriz, Moutinho
    Beatriz, Pinto
    Rita, Cardoso
    Helena, Alves
    Monica, Botelho
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2019, 20 (04) : 327 - 331
  • [37] Alterations in prothrombin time and activated partial thromboplastin time in patients with acute myocardial infarction
    Khan, Haseeb A.
    Alhomida, Abdullah S.
    Al Rammah, Tamader Y.
    Sobki, Samia H.
    Ola, Mohammad S.
    Khan, Adnan A.
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2013, 6 (04): : 294 - 297
  • [38] Prothrombin time, activated partial thromboplastin time and fibrinogen values in Mediterranean marine teleosts
    M. Pavlidis
    M. Berry
    C. Kokkari
    M. Kentouri
    Fish Physiology and Biochemistry, 1999, 21 : 335 - 343
  • [39] Prothrombin time, activated partial thromboplastin time and fibrinogen values in Mediterranean marine teleosts
    Pavlidis, M
    Berry, M
    Kokkari, C
    Kentouri, M
    FISH PHYSIOLOGY AND BIOCHEMISTRY, 1999, 21 (04) : 335 - 343
  • [40] Prolongation of the prothrombin time and activated partial thromboplastin time in children with sickle cell disease
    Raffini, Leslie J.
    Niebanck, Alison E.
    Hrusovsky, Joanne
    Stevens, Amanda
    Blackwood-Chirchir, Anne
    Ohene-Frempong, Kwaku
    Kwiatkowski, Janet L.
    PEDIATRIC BLOOD & CANCER, 2006, 47 (05) : 589 - 593